Current management of hepatitis C virus infection in patients with HIV co-infection
about
The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of careHepatitis C.Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future DirectionsEfficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.Cellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patientsLiver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patientsHepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfectionSustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysis.Viral hepatitis and human immunodeficiency virus co-infections in AsiaUpdate on Hepatitis C Virus and HIV Coinfection.HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary CareSpontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysisHigh Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany.Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.Update on HIV/HCV coinfection.Treatment decisions and contemporary versus pending treatments for hepatitis C.Interferon-free regimens for hepatitis C: combine and conquer.Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV.Treatment of chronic hepatitis C in patients with HIV/HCV coinfectionClinical pharmacology profile of boceprevir, a hepatitis C virus NS3 protease inhibitor: focus on drug-drug interactions.HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype.Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection.Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals.HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study.Effect of HCV, HIV and coinfection in kidney transplant recipients: mate kidney analyses.KASL clinical practice guidelines: management of hepatitis C.Global, regional, and national prevalence of hepatitis B infection in the general and key populations living with HIV: a systematic review and meta-analysis protocol
P2860
Q26991549-D54D52F9-771A-4851-AC6E-32F0815E2602Q28084654-714524C6-789E-467A-A8FF-A4A19A4E8B6EQ30244921-E7388F00-24A1-47D8-B19A-D79FF1CFCB18Q33423922-0BC9BFAC-6252-42D0-B96C-2DBDADF1F19EQ33584149-2B6CF003-E9B2-419C-8770-A5DF28A89AECQ33889885-EB864902-155F-4B7E-BD36-40F1F85379A6Q34298877-B76A819B-FF0F-42D1-B4E9-BD52C676C672Q34362476-4C5E8CDD-B165-4908-BF37-68B0F7146951Q35567832-F5A51AB8-FEF2-486C-88D6-F87224251F19Q35906047-8F67136D-489F-4236-B667-E4CCFCC97416Q36015496-40B89CDB-4E75-4503-A54E-5E9BEE91F1E9Q36123263-2B4A5BA4-30A6-4FF9-990D-A3F8A77B79F2Q36268801-F498AF15-0A1F-44A1-8423-9645560C2F01Q37202576-F2E9DCCD-4849-4CF8-9C7D-AF98E1DB030AQ38119893-0F8FFB3D-13D7-4BA8-99C3-DBAF37E63BA9Q38135774-CAA483A3-036D-474A-AA42-4EEB2E674AC3Q38156403-7AF25127-7126-49DC-A5DD-B9CC1F238586Q38172277-5683B59C-B154-4FB5-B93C-0392E5EE51F5Q38352572-484B1AEF-E3E6-4D05-9B7E-3BF54E030E86Q38383083-E8F6A838-1025-48DB-9E2A-7909E93008CCQ40069643-14D0E6C4-E8B1-4790-8E79-5F36E00C5150Q40078485-F9CD1FE6-0A13-4D2E-878F-3DD35FC624BEQ40856847-C5BACABA-6E79-45DA-9243-19C9E334A084Q41984358-1742B714-0A13-4D2C-8A68-87FF0A1CE301Q42201616-65BDCEDA-BD16-4015-9FDC-F5C06B736228Q51836024-48D9E9DB-8230-4D13-8B3D-E01B538B0E99Q59128554-0546177B-9854-498D-AF6F-D5F55C14CF9B
P2860
Current management of hepatitis C virus infection in patients with HIV co-infection
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Current management of hepatitis C virus infection in patients with HIV co-infection
@ast
Current management of hepatitis C virus infection in patients with HIV co-infection
@en
type
label
Current management of hepatitis C virus infection in patients with HIV co-infection
@ast
Current management of hepatitis C virus infection in patients with HIV co-infection
@en
prefLabel
Current management of hepatitis C virus infection in patients with HIV co-infection
@ast
Current management of hepatitis C virus infection in patients with HIV co-infection
@en
P2860
P356
P1476
Current management of hepatitis C virus infection in patients with HIV co-infection
@en
P2093
Mark S Sulkowski
P2860
P304
P356
10.1093/INFDIS/JIS764
P407
P478
207 Suppl 1
P577
2013-03-01T00:00:00Z